Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 5/2019

01-05-2019 | Letter to the Editor

Lymphomatoid granulomatosis mimicking cancer and sarcoidosis

Authors: Grosse Alexandra, Grosse Claudia

Published in: Annals of Hematology | Issue 5/2019

Login to get access

Abstract

Two cases of misdiagnoses of lymphomatoid granulomatosis are discussed here. Lymphomatoid granulomatosis is an Epstein-Barr virus-associated lymphoproliferative disorder with aggressive behavior. Due to its rarity and many presentations, delay in diagnosis and treatment is common. Its histological features including large atypical B-cells, T cell predominance, angiocentricity, necrosis, and evidence of EBV-positive cells should elicit the diagnosis of lymphomatoid granulomatosis. The settings that are described here have not yet been described in the literature.
Literature
1.
2.
Nichols PW, Koss M, Levine AM, Lukes RJ (1982) Lymphomatoid granulomatosis: a T-cell disorder? Am J Med 72:467–471CrossRefPubMed
3.
Lipford EH Jr, Margolick JB, Longo DL, Fauci AS, Jaffe ES (1988) Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 72:1674–1681
4.
Ammannagari N, Srivali N, Price C, Ungprasert P, Leonardo J (2013) Lymphomatoid granulomatosis masquerading as pneumonia. Ann Hematol 92:981–983CrossRefPubMed
5.
Bartosik W, Raza A, Kalimuthu S, Fabre A (2012) Pulmonary lymphomatoid granulomatosis mimicking lung cancer. Interact Cardiovasc Thorac Surg 14:662–664
6.
Braham E, Ayadi-Kaddour A, Smati B, Ben Mrad S, Besbes M, el Mezni F (2008) Lymphomatoid granulomatosis mimicking interstitial lung disease. Respirology 13:1085–1087PubMed
7.
Srivali N, Thongprayoon C, Cheungpasitporn W, Ungprasert P (2016) Lymphomatoid granulomatosis mimicking vasculitis. Ann Hematol 95:345–346
8.
Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L, Davies-Hill T, Raffeld M, Wilson WH, Jaffe ES (2015) Lymphomatoid granulomatosis-a single institute experience: pathologic findings and clinical correlations. Am J Surg Pathol 39:141–156CrossRefPubMedPubMedCentral
9.
Katzenstein AL, Doxtader E, Narendra S (2010) Lymphomatoid granulomatosis: insights gained over 4 decades. Am J Surg Pathol 34:e35–e48
10.
Fujimaki M, Kawajiri S, Ichikawa K, Tomizawa Y, Nakazato T, Noda K, Hattori N, Koike M, Okuma Y (2015) Lymphomatoid granulomatosis with central nervous system involvement successfully treated with cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER therapy) followed by brain irradiation: a case study. CNS Neurosci Ther 21:610–612
Metadata
Title
Lymphomatoid granulomatosis mimicking cancer and sarcoidosis
Authors
Grosse Alexandra
Grosse Claudia
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3505-4

Other articles of this Issue 5/2019

Annals of Hematology 5/2019 Go to the issue

Original Article

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

Original Article

Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia

Original Article

International external quality assurance of JAK2 V617F quantification

Original Article

Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis

Original Article

Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study

Letter to the Editor

Coexistence of t(5;17)/NPM1-RARA and t(9;22)/BCR-ABL1 in chronic myeloid leukemia at initial diagnosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits